McSally And McConnell Are Obstructing Drug Pricing Reforms
FACT CHECK: McSally And McConnell Are Obstructing Drug Pricing Reforms
PHOENIX — In a new interview, U.S. Sen. Martha McSally misrepresented the facts on Mitch McConnell’s obstruction and refusal to support H.R. 3, a bipartisan, U.S. House-passed bill that’s estimated to lower drug costs by empowering Medicare to negotiate down the cost of the most expensive prescription drugs.
McSally has for months refused to support the bill, which also happens to be opposed by a pharmaceutical industry-linked group that last year spent $1 million to keep McSally’s vote in the Senate, plus another $1 million boosting McSally’s failed 2018 campaign.
When asked whether she believes Congress will advance her bill, McSally blamed Democrats, rather than say why she’s siding with Mitch McConnell and her pharmaceutical industry backers, as they block H.R. 3:
MCSALLY: I’m concerned in this election year, for sure, the Democrats want to obstruct anything that’s positive […] This should not be a partisan issue, the cost of prescription drugs is too high, we’ve got to keep putting the public pressure on them to move something forward to address this issue.
Despite her partisan rhetoric, the truth is that it’s McSally who has sided with the pharmaceutical industry and Mitch McConnell as he obstructs a bipartisan bill that would secure lower drug costs for Arizonans.
“Arizonans know that Martha McSally can’t be trusted on health care,” said Brad Bainum, Arizona Democratic Party spokesperson. “When it comes to prescription drug prices, Senator McSally is standing with Mitch McConnell and her pharma backers as they obstruct needed reforms that can lower drug prices.”